Enzo Biochem
(NYSE) ENZ
Enzo Biochem Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$27.48M
Net Income (TTM)
$21.08M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ENZ News
6 Reasons to Worry About Next Week
3 Stocks Ready to Roar
The Wall Street Buy List
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Enzo Biochem
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
136
CEO
Kara Cannon
Website
www.enzo.comHeadquarters
New York City, NY 10022, US
ENZ Financials
Key Financial Metrics (TTM)
Gross Margin
44%
Operating Margin
-40%
Net Income Margin
-39%
Return on Equity
-17%
Return on Capital
-17%
Return on Assets
-12%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-1.38%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$14.63M
Operating Income
$9.82M
EBITDA
$8.35M
Operating Cash Flow
$26.26M
Capital Expenditure
$545.00K
Free Cash Flow
$26.80M
Cash & ST Invst.
$52.37M
Total Debt
$3.51M
Enzo Biochem Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.40M
-20.2%
Gross Profit
$2.48M
-33.5%
Gross Margin
38.80%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
125
N/A
Net Income
$2.79M
+7.6%
EBITDA
$3.07M
-202.9%
Quarterly Fundamentals
Net Cash
$33.69M
-38.6%
Accounts Receivable
$4.31M
+9.5%
Inventory
$5.71M
-22.0%
Long Term Debt
$2.05M
-26.2%
Short Term Debt
$954.00K
-78.7%
Return on Assets
-12.12%
N/A
Return on Invested Capital
-17.34%
N/A
Free Cash Flow
$3.61M
-20.0%
Operating Cash Flow
$3.22M
-12.5%